OCTOBER 4, 2001 11A
Zahn's status as coach
'Yawn: Wake me when
somebody cranks 80
s Barry Bonds going to break the
record? Did he already? Whatever,
I don't really care. Wake me when
someone hits 80. I'm going to go take a
I have not been able to pinpoint the
reason for my indifference toward this
year's attack on the homerun record.
I'm sure it is the result of several fac-
tors - Bonds has been branded as a
bad guy, the media "frenzy" isn't half
as feverish as in 1998 or maybe it's just
that I'm becoming a more apathetic
person in general each passing day.
Three years ago, the chase was excit-
ing. The 1998 season served as a fan-
tastic backdrop for the McGwire-Sosa
horserace. The homerun record was the
centerpiece of a year filled with unpar-
alleled accomplishments such as the
Yankees' 125 victories, Kerry Wood's
20-strikeout game as a rookie and
Roger Clemens' fifth Cy Young award.
The fact that two sluggers emerged
that year to compete against history as
well as each other made for a fascinat-
ing storyline. But unless Sosa busts out
with eight or nine home runs today (or
if Deivi Cruz hits about 62 to get back
in the chase), Bonds will continue as
the sole challenger.
What's more is that in 1998, it was
new, it was different, it was something
that hadn't really been seen in 37 years.
Now the novelty has worn off. Bonds
is just a Johnny-come-lately. I saw this
In 1998, the number 61 was sacred,
just as 60 had been for 34 years before
1961. When McGwire-cranked out 70,
that was supposed to be the number
fans were going to be looking at for
another 30 years.
But Bonds has obliterated Mark
McGwire's homerun pace of 1998. The
only thing that has stopped him from
destroying the record itself are games
ike Sunday's when the Padres threw
him one strike in I I pitches. Whether
he breaks the record or not, the worst
fears for McGwire fans have already
been confirmed. The number 70 is not
Now there is a palpable fear among
many baseball fans that if Bonds sur-
passes 70, the homerun record will be
cheapened. The excitement of 1998
was suddenly all for naught and the
record is at risk every year.
Babe Ruth's record of 60 in 1927
came under siege before too long. Jim-
mie Foxx hit 58 home runs in 1932.
Hank Greenberg equaled Foxx's feat in
1938. The number 60 looked vulnera-
ble even before Mickey Mantle, Roger
Maris and a 162-game schedule, but no
.one said the sky was falling.
I don't find myself actively rooting
for or against Bonds (such a move
would ruin my whole apathy phase),
but I certainly won't be bothered by
seeing McGwire's record passed. This
does not mean that every three years
we should come to expect a new home-
run mark. Eventually, an impossibly
high standard will be set and will last
for another 20 or 30 years.
The number might be established
this year, or maybe a few years from
now. The number might be 75, or 80,
or it's still possible it could stay at 70.
But some day in the future, we're going
to go through this homerun chase
again, and marvel at such high numbers
that were once only attained by leg-
endary names such as Sosa, McGwire
and Bonds. And Deivi Cruz.
But not enough years have passed
since the last time I saw 70 homers hit
for me to be bewildered and captivated
by seeing it done again. I can't say
exactly how many years must go by
before a homerun chase will be excit-
ing again. I guess whenever I get up
from my nap.
Benjamin Singer would be more excited
if Cal Ripken had 70 homeruns. He can
be reached at firstname.lastname@example.org.
By Benjamin Singer
Daily Sports Editor
When the Michigan baseball team
went to practice on Tuesday, it
found associate athletic director
Megan McCallister waiting to
inform them that coach Geoff Zahn
was in a meeting with Unviersity
administrators. Zahn was missing
from yesterday's practice as well.
"He wasn't around," junior Jere-
my Stein said. "We were told it's
between him and the athletic depart-
The Ann Arbor News reported
Zahn's desk was cleaned out and
speculation of a coaching change.
has begun to arise. It also reported
that pitching coach Steve Foster
announced his resignation last Fri-
day. But Foster did show up to the
past two day's practices.
"I know there's been other offers"
from other schools for Foster, Stein
Foster - once a minor league
pitcher who was in the Reds' system
with former Wolverines including
Barry Larkin, Hal Morris and Chris
Sabo - was entering his second
year as Michigan's pitching coach.
Athletic Director Bill Martin
could not be reached for comment.
Zahn was suspended for several
days by Michigan in June of 2000
after players sent the athletic depart-
ment letters complaining of Zahn's
In six years as coach of Michigan,
Zahn has a 162-168-2 record,
including a Big Ten Tournament
championship and NCAA appear-
ance in 1999. He also earned the
1997 Big Ten Conference Coach of
Last year's team finished 28-28 as
runner-ups in the Big Ten Tourna-
Zahn pitched in the Major
Leagues for 13 years with four dif-
After coaching Michigan baseball for six years, Geoff Zahn may be on his way out.
He has been absent during the past two practices.
After losses, Happy Valley not so happy
By Dave Horn
Daily Sports Writer
"We are? Penn State!" The familiar
chant of the fans in Happy Valley will
be less a declaration this year, and more
a reminder. Fans in the Bryce Jordan
Center may not recognize their team,
which lost four starters (three to gradu-
ation, one to a transfer) during the off-
Gone are the Crispin brothers - Jon
and Joe - as well as guard Titus Ivory
and forward Gyasi Cline-Heard. Those
four made up the foundation of a team
that surprised many by advancing to
last year's Sweet Sixteen via wins over
Providence and North Carolina, before
falling to in-state foe Temple.
What is left are a couple of low-level
contributors - junior guard Brandon
Watkins and senior forward Tyler
BIG TEN PREVIEWS
As the college basketball season approaches,-
inside scoop on every Big Ten team as they
count down the days until they release their spe- CONFERENCE
cial section "Tipoff" in November.
him one of the most valuable post play-
ers in the Big Ten.
Dunn, however, does not recognize-
the urgency of quality production down
low. He seems instead to recognize the
2001-02 campaign as a rebuilding year,
and with his new five-year contract
extension, is able to plan long-term.
"I would hope that Tyler doesn't feel
any pressure at all," Dunn said. "I
would like all the pressure to be on me
as opposed to any of the players. Tyler
is in a position to enjoy his senior year
and all of the success that goes with it.
"I think the only pressure I would
See PENN STATE, Page 12A
Smith -- who managed little produc-
tion last season. Things may get pretty
sad in Happy Valley, as 'the Nittany
Lions will likely fall to the bottom of
the conference in an obvious transition
But head coach Jerry Dunn is opti-
mistic, and expects his young team to
grow into itself.
"I think a new cast with a lot of
young players is challenging but also
exciting," Dunn said.
Smith, who last year averaged 7.6
points per game, 1.2 rebounds per game
and 4.5 assists per game, will now be
the go-to guy down low. His rebound-
ing - especially on the offensive glass
- will need to improve considerably if
he is to even begin to fill the large
shoes left by Cline-Heard. The departed
big man averaged 16 points and just
over eight rebounds per game, making
Two goalies for M,
but just one goal
By Jim Weber
Daily Sports Writer to this new defense has made life easie
Career Development & Care
P a s s i c
0 w D .*Achieve powerful results in all
P RS 0 N L .Formulate a ptan for victory
for your whole life
Livelife more fully and
with greater meaning
. Stress Manaeement . Communication Skills
After posting three straight shutouts,
sophomore goalie Suzie Grech still
doesn't know if she will be starting
i tomorrow against Ohio State.
Grech said the decision will be made
during the week as the Wolverines pre-
pare for this weekend's games. Grech
has split time in net with fellow sopho-
more Bre Bennett and could continue to
do so. Bennett started the season in goal
against Loyola-Marymount but has
steadily seen her playing time decrease
throughout the season. She hasn't start-
ed a game since Michigan's home open-
er against Kentucky on Sept. 7.
Grech made 16 saves in her three
shutout performances, including eight
saves during Michigan's 1-0 overtime
victory over Wisconsin last Sunday.
At 5-foot-Il, Grech has a distinct
height advantage over the 5-foot-5 Ben-
nett. Assistant coach Scott Forrester said
that with her height, Grech is better able
to defend high shots on goal.
After making the save, Forrester said
that Grech displays a lot of power on
her punts. She is also suited to handle
the pressure of a Big Ten season after
starting seven games as a freshman -
including one against top-ranked and
undefeated Notre Dame.
"She does have a lot of high-level
game experience, which is very impor-
tant to that position," Forrester said.
Although Grech is a talented goalie,
she does not depend solely on her physi-
"As much as goalie is a physical posi-
tion, it is also very mental," Grech said.
The mental aspect of the game is
even more important for the two Michi-
"It's not just me getting me shutout
- it's the whole team." she said.
But Grech shouldn't look over her
shoulder because Bennett has impressed
the coaches as well.
"I think both keepers have improved
tremendously. It's not like (Grech) has
set herself that far away from Bre," For-
"Gettin a coach in college
was the best thing I ever did"
- CEO, Computer Gaming Company Call No and ceive a
"My coach helped me link COACHING SESSION!
t my passions with my career" CI*
VP Mkt, Outdoor Adventure Co. Call Toll Free
- "Idefinitelytakejob candidates or Staff@Coachin Circlescorn
more seriously if they have been g -
R coached"- Head of Recruiting, Fortune 100. d
a Coaching Circles is one of the largest and most respected professional and personal
coaching companies in the country. For more information - CoachingCircles.com
0 I00 - 0 - 0
Contraceptive In ection] frtk controloultkr aout just
medroxyprogesterone acetate injectable suspension
+ x( a year
DEPO-PROVERA' Contraceptive Injection
(medroxyprogesterone acetate injectable suspension. USP)
This product is intended to prevent pregnancy. It does not protect against HIV
infection (AIDS) and other sexually transmitted diseases.
What is DEPO-PROVERA Contraceptive Injection?
DEPO-PROVERA Contraceptive Injection is a form of birth control that is given as an intramus-
cular injection (a shot) in the buttock or upper arm once every 3 months (13 weeks). To con-
tinue your contraceptive protection, you must return for your next injection promptly at the end
of 3 months (13 weeks). DEPO-PROVERA contains medroxyprogesterone acetate, a chemical
similar to (but not the same as) the natural hormone progesterone, which is produced by your
ovaries during the second half of your menstrual cycle. DEPO-PROVERA acts by preventing your
egg cells from npening. If an egg is not released from the ovaries during your menstrual cycle, it
cannot become fertilized by sperm and result in pregnancy. DEPO-PROVERA also causes
changes in the lining of your.uterus that make it less likely for pregnancy to occur
How effective is DEPO-PROVERA Contraceptive injection?
The efficacy of DEPO-PROVERA Contraceptive Injection depends on following the recommend-
ed dosage schedule exactly (see -How often do I get my shot of DEPO-PROVERA Contraceptive
Injection.'), To make sure you are not pregnant when you first get DEPO-PROVERA
Contraceptive Injection, your first injection must be given ONLY during the first 5 days of a
normal menstrual period; ONLY within the first 5 days after childbirth if not breast-feeding: and,
if exclusively breast-feeding. ONLY at the sixth week after childbirth. It is a long-term injectable
contraceptive when administered at 3-month ( 13-week) intervals. DEPO- PROVERA
Contraceptive Injection is over 99% effective, making it one of the most reliable methods of birth
control available. This means that the average annual pregnancy rate is less than one for every
100 women who use DEPO-PROVERA. The effectiveness of most contraceptive methods
depends in part on how reliably each woman uses the method. The effectiveness of
DEPO-PROVERA depends only on the patient returning every 3 months (13 weeks) for her next
injection. Your health-care provider will help you compare DEPO-PROVERA with other contra-
ceptive methods and give you the information you need in order to decde which contraceptive
method is the right choice for you.
The following table shows the percent of women who got pregnant while using different kinds of
contraceptive methods. It gives both the lowest expected rate of pregnancy (the rate expected
in women who use each method exactly as it should be used) and.the typical rate of pregnancy
(which includes women who became pregnant because they forgot to use their birth control or
because they did not follow the directions exactly).
Percent of Women Experiencing an Accidental Pregnancy
in the First Year of Continuous Use
if you have had cancer of the breast
" if you have had a stroke
. if you have or have had blood clots (phlebitis) in your legs
- if you have problems with your liver or liver disease
- if you are allergic to DEPO-PROVERA (medroxyprogesterone acetate or any of its other
What other things should I consider before using DEPO-PROVERA
You will have a physical examination before your doctor prescribes DEPO-PROVERA. It is impor-
tant to tell your health-care provider if you have any of the following:
a family history of breast cancer
- an abnormal mammogram (breast x-ray), fbrocystic breast disease, breast nodules or lumps, or
bleeding from your nipples
- kidney disease
- irregular or scanty menstrual periods
- high blood pressure
" migraine headaches
- epilepsy (convulsions or seizures)
- diabetes or a family history of diabetes
a history of depression
- if you are taking any prescription or over-the-counter medications
This product is intended to prevent pregnancy. It does not protect against trans-
mission of HIV (AIDS) and other sexually transmitted diseases such as chlamy-
dia, genital herpes, genital warts, gonorrhea, hepatitis B, and syphilis.
What if I want to become pregnant after using DEPO-PROVERA Contraceptive
Because DEPO-PROVERA is a long-actingbirth control method, it takes some time after your last
injection for its effect to wear off. Based onmthe results from a large-study done in the United States,
for women who stop using DEPO-PROVERA in order to become pregnant, it is expected that
about half of those who become pregnant will do so in about 10 months after their last injection;
about two thirds of those who become pregnant wili do so in about 12 months; about 83% of
those who become pregnant will do so in about I5 months; and about 93% of those who become
pregnant will do so in about I 8 months after their last injection. The length of time you use
DEPO-PROVERA has no effect on how long it takes you to become pregnantafter you stop using it.
What are the risks of using DEPO-PROVE RA Contraceptive Injection?
}.Irregulor Menstrual Bleeding
The side effect reported most frequently by women who use DEPO-PROVERA for contracep-
tion is a change in their normal menstrual cycle. During the first year of using DEPO-PROVERA,
you might have one or more of the following changes: irregular or unpredictable bleeding or spot-
ting, an increase or decrease in menstrual bleeding, or no bleeding at all. Unusually heavy or con-
tinuous bleeding, however is not a usual effect of DEPO-PROVERA: and if this happens, you should
see your health-care provider right away With continued use of DEPO-PROVERA, bleeding usu-
ally decreases, and many women stop having periods completely in clinical studies of
DEPO-PROVERA, 55% of the women studied reported no menstrual bleeding (amenorrhea)
after I year of use, and 68% of the women studied reported no menstrual bleeding after 2 years
of use. The reason that your periods stop is because DEPO-PROVERA causes a resting state in
Women who use hormone-based contraceptives may have an increased risk of blood clots or
stroke. Also, if a contraceptive method fails, there is a possibility that the fertilized egg weli begin
to develop outside of the uterus (ectopic pregnancy). While these events are rare, you should
tell your health-care provider if you have any of the problems listed in the next section.
What symptoms mar signal problems while using DEPO-PROVERA
Call your health-care provider immediately if any of these problems occur following an injection
- sharp chest pain, coughing up of blood, or sudden shortness of breath (indicating a possible clot
in the lung)
sudden severe headache or vomiting, dizziness or fainting, problems with your eyesight or
speech, weakness, or numbness in an arm or leg (indicating a possible stroke)
- severe- pain or swelling in the calf (indicating a possible clot in the leg)
- unusually heavy vaginal bleeding
- severe pain or tenderness in the lower abdominal area
persistentpain, pus, or bleeding at the injection site
what are e possible side effects of DEPO-PROVERA Contraceptive Injection?
I Weight Goin
You may experience a weight gain while you are using DEPO-PROVERA. About two thirds of
the women who used DEP0-PROVERA in clinical trials reported a weight gain of about 5 pounds
during the first year of use. You may continue to gain weight after the frst year. Women in one
large study who used DEPO-PROVERA for 2 years gained an average total of 8:1 pounds over
those 2 years. or approximately 4 pounds per year Women who continued for 4 years gained an
average total of 13.8 pounds over those 4 years, or approximately 3.5 pounds per year Women
who continued for 6 years gained an average total of i6.5 pounds over those 6 years, or approx-
imately 2.75 pounds per year.
20.ther Side Effects
In a clinical study of over 3,900 women who used DEPO-PROVERA for up to 7 years, some
women reported the following effects that may or may not have been related to their use of
DEPO-PROVERA: Irregular menstrual bleeding, amenorrhea, headache, nervousness, abdominal
cramps, dizziness, weakness or fatigue, decreased sexual desire, leg cramps,'nausea, vaginal dis-
charge or irritation, breast swelling and tenderness, bloating, swelling of the hands or feet, back-
ache, depression, insomnia, acne, pelvic pain, no hair growth or excessive hair loss, rash, hot flash-
es, and joint pain. Other problems were reported by very few of the women in the clinical trials,
but some of these could be serious. These include convulsions, jaundice, unnary tract infections,
allergic reactions, fainting, paralysis, osteoporosis, lack of return to fertility, deep vein thrombosis,
pulmonary embolus, breast cancer, or cervical cancer If these or any other problems occur dur-
in your use of DEPO-PROVERA, discuss-them with your health-care provider.
Should any precautions be followed during use of DEPO-PROVERA
During the time you are using DEPO-PROVERA for contraception, you may skip a period, or your
periods may stop completely if you have been receiving your DEPO-PROVEPA injections regu-
larly every 3 months (13 weeks), then you are probably not pregnant. However, if you think that
you may be pregnant, see your health-care provider.
2.Loborotory Test Interactions
If you are scheduled for any laboratory tests, tell your health-care provider that you are using
Method Expected Typical
DEPO-PROVERA 0.3 03
implants (Norplant) 0.2 0.2"
Female sterization 0.2 0.4
Mae ailann 01 1